McFarlane Neil F. Insider Trades & Stock Holdings

President and CEO · Zevra Therapeutics, Inc. · Latest filing Oct 12, 2026

McFarlane Neil F., President and CEO at Zevra Therapeutics, Inc. has 1 Form 4 trade on file since Oct 12, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($224.95K), net -$224.95K. Latest filing: disposed of 20K shares of $ZVRA on Oct 12, 2026 at $11.25.

Trades on file

1

Open-market bought

$0

Open-market sold

$224.95K

Net open-market

-$224.95K

Latest filing

Oct 12, 2026

All insider trades by McFarlane Neil F.

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 12, 2026	$ZVRA	Sell (Open-market sale) 10b5-1	20K	$11.25	$224.95K						President and CEO		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks McFarlane Neil F. traded

• $ZVRA

Frequently asked questions

Has McFarlane Neil F. been buying or selling stock?

McFarlane Neil F. has 0 open-market purchases and 1 open-market sale on file, net -$224.95K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was McFarlane Neil F.'s latest insider trade?

disposed of 20K shares of $ZVRA on Oct 12, 2026 at $11.25.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.